Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

被引：0
|
作者：
Robert M. Anthenelli
Michael Gaffney
Neal L. Benowitz
Robert West
Thomas McRae
Cristina Russ
David Lawrence
Lisa St. Aubin
Alok Krishen
A. Eden Evins
机构：
[1] University of California,Department of Psychiatry
[2] San Diego,Department of Medicine
[3] Pfizer,undefined
[4] University of California,undefined
[5] University College,undefined
[6] PAREXEL International on behalf of GlaxoSmithKline,undefined
[7] Massachusetts General Hospital and Harvard Medical School,undefined
来源：
Journal of General Internal Medicine | 2019年 / 34卷
关键词：
neuropsychiatric adverse event; smoking cessation medication; varenicline; predictors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：862 / 870
页数：8
相关论文
共 50 条
  • [1] Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
    Anthenelli, Robert M.
    Gaffney, Michael
    Benowitz, Neal L.
    West, Robert
    McRae, Thomas
    Russ, Cristina
    Lawrence, David
    St Aubin, Lisa
    Krishen, Alok
    Evins, A. Eden
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (06) : 862 - 870
  • [2] Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial
    Mckee, Sherry A.
    Lawrence, David E.
    Saccone, Phillip
    Mcrae, Thomas
    Anthenelli, Robert M.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2023, 8
  • [3] Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events,Treatment Adherence, and Smoking Cessation
    Correa, John B.
    Lawrence, David
    McKenna, Benjamin S.
    Gaznick, Natassia
    Saccone, Phillip A.
    Dubrava, Sarah
    Doran, Neal
    Anthenelli, Robert M.
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (10) : 1646 - 1655
  • [4] Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial
    Ebbert, Jon
    Jimenez-Ruiz, Carlos
    Dutro, Michael P.
    Fisher, Matt
    Li, Jing
    Hays, J. Taylor
    MAYO CLINIC PROCEEDINGS, 2021, 96 (07) : 1801 - 1811
  • [5] Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
    Truong, Van Thi Thanh
    Green, Charles
    Pedroza, Claudia
    Hwang, Lu-Yu
    Rajan, Suja S.
    Suchting, Robert
    Cinciripini, Paul
    Tyndale, Rachel F.
    Lerman, Caryn
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [6] Predictors of Smoking Cessation Among College Students in a Pragmatic Randomized Controlled Trial
    Miren I. Pardavila-Belio
    Miguel Ruiz-Canela
    Navidad Canga-Armayor
    Prevention Science, 2019, 20 : 765 - 775
  • [7] Predictors of Smoking Cessation Among College Students in a Pragmatic Randomized Controlled Trial
    Pardavila-Belio, Miren I.
    Ruiz-Canela, Miguel
    Canga-Armayor, Navidad
    PREVENTION SCIENCE, 2019, 20 (05) : 765 - 775
  • [8] Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES
    West, Robert
    Evins, A. Eden
    Benowitz, Neal L.
    Russ, Cristina
    McRae, Thomas
    Lawrence, David
    St Aubin, Lisa
    Krishen, Alok
    Maravic, Melissa C.
    Anthenelli, Robert M.
    ADDICTION, 2018, 113 (08) : 1507 - 1516
  • [9] Adherence to Blended or Face-to-Face Smoking Cessation Treatment and Predictors of Adherence: Randomized Controlled Trial
    Siemer, Lutz
    Brusse-Keizer, Marjolein G. J.
    Postel, Marloes G.
    Ben Allouch, Somaya
    Sanderman, Robbert
    Pieterse, Marcel E.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (07)
  • [10] Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial
    Ayers, Catherine R.
    Heffner, Jaimee L.
    Russ, Cristina
    Lawrence, David
    McRae, Thomas
    Evins, A. Eden
    Anthenelli, Robert M.
    DEPRESSION AND ANXIETY, 2020, 37 (03) : 247 - 260
12345